Expansion of the quality of care index on breast cancer and its risk factors using the global burden of disease study 2019

BACKGROUND: Breast cancer (BC), as the top neoplasm in prevalence and mortality in females, imposes a heavy burden on health systems. Evaluation of quality of care and management of patients with BC and its responsible risk factors was the aim of this study. METHODS: We retrieved epidemiologic data...

Full description

Bibliographic Details
Published in:Cancer Medicine
Main Authors: Azadnajafabad, Sina, Saeedi Moghaddam, Sahar, Keykhaei, Mohammad, Shobeiri, Parnian, Rezaei, Negar, Ghasemi, Erfan, Mohammadi, Esmaeil, Ahmadi, Naser, Ghamari, Azin, Shahin, Sarvenaz, Rezaei, Nazila, Aghili, Mahdi, Kaviani, Ahmad, Larijani, Bagher, Farzadfar, Farshad
Format: Text
Language:English
Published: John Wiley and Sons Inc. 2022
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883412/
http://www.ncbi.nlm.nih.gov/pubmed/35770711
https://doi.org/10.1002/cam4.4951
id ftpubmed:oai:pubmedcentral.nih.gov:9883412
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:9883412 2023-05-15T16:52:13+02:00 Expansion of the quality of care index on breast cancer and its risk factors using the global burden of disease study 2019 Azadnajafabad, Sina Saeedi Moghaddam, Sahar Keykhaei, Mohammad Shobeiri, Parnian Rezaei, Negar Ghasemi, Erfan Mohammadi, Esmaeil Ahmadi, Naser Ghamari, Azin Shahin, Sarvenaz Rezaei, Nazila Aghili, Mahdi Kaviani, Ahmad Larijani, Bagher Farzadfar, Farshad 2022-06-30 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883412/ http://www.ncbi.nlm.nih.gov/pubmed/35770711 https://doi.org/10.1002/cam4.4951 en eng John Wiley and Sons Inc. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883412/ http://www.ncbi.nlm.nih.gov/pubmed/35770711 http://dx.doi.org/10.1002/cam4.4951 © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. CC-BY Cancer Med RESEARCH ARTICLES Text 2022 ftpubmed https://doi.org/10.1002/cam4.4951 2023-02-05T01:51:36Z BACKGROUND: Breast cancer (BC), as the top neoplasm in prevalence and mortality in females, imposes a heavy burden on health systems. Evaluation of quality of care and management of patients with BC and its responsible risk factors was the aim of this study. METHODS: We retrieved epidemiologic data of BC from the Global Burden of Disease (GBD) 1990–2019 database. Epidemiology and burden of BC and its risk factors were explored besides the Quality of Care Index (QCI) introduced before, to assess the provided care for patients with BC in various scales. Provided care for BC risk factors was investigated by their impact on years of life lost and years lived with disability by a novel risk factor quality index (rQCI). We used the socio‐demographic index (SDI) to compare results in different socio‐economic levels. RESULTS: In 2019, 1,977,212 (95% UI: 1,807,615–2,145,215) new cases of BC in females and 25,143 (22,231–27,786) in males was diagnosed and this major cancer caused 688,562 (635,323–739,571) deaths in females and 12,098 (10,693–13,322) deaths in males, globally. The all‐age number of deaths and disability‐adjusted life years attributed to BC risk factors in females had an increasing pattern, with a more prominent pattern in metabolic risks. The global estimated age‐standardized QCI for BC in females in 2019 was 78.7. The estimated QCI was highest in high SDI regions (95.7). The top countries with the highest calculated QCI in 2019 were Iceland (100), Japan (99.8), and Finland (98.8), and the bottom countries were Mozambique (16.0), Somalia (8.2), and Central African Republic (5.3). The global estimated age‐standardized rQCI for females was 82.2 in 2019. CONCLUSION: In spite of the partially restrained burden of BC in recent years, the attributable burden to risk factors has increased remarkably. Countries with higher SDI provided better care regarding both the condition and its responsible risk factors. Text Iceland PubMed Central (PMC) Cancer Medicine 12 2 1729 1743
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic RESEARCH ARTICLES
spellingShingle RESEARCH ARTICLES
Azadnajafabad, Sina
Saeedi Moghaddam, Sahar
Keykhaei, Mohammad
Shobeiri, Parnian
Rezaei, Negar
Ghasemi, Erfan
Mohammadi, Esmaeil
Ahmadi, Naser
Ghamari, Azin
Shahin, Sarvenaz
Rezaei, Nazila
Aghili, Mahdi
Kaviani, Ahmad
Larijani, Bagher
Farzadfar, Farshad
Expansion of the quality of care index on breast cancer and its risk factors using the global burden of disease study 2019
topic_facet RESEARCH ARTICLES
description BACKGROUND: Breast cancer (BC), as the top neoplasm in prevalence and mortality in females, imposes a heavy burden on health systems. Evaluation of quality of care and management of patients with BC and its responsible risk factors was the aim of this study. METHODS: We retrieved epidemiologic data of BC from the Global Burden of Disease (GBD) 1990–2019 database. Epidemiology and burden of BC and its risk factors were explored besides the Quality of Care Index (QCI) introduced before, to assess the provided care for patients with BC in various scales. Provided care for BC risk factors was investigated by their impact on years of life lost and years lived with disability by a novel risk factor quality index (rQCI). We used the socio‐demographic index (SDI) to compare results in different socio‐economic levels. RESULTS: In 2019, 1,977,212 (95% UI: 1,807,615–2,145,215) new cases of BC in females and 25,143 (22,231–27,786) in males was diagnosed and this major cancer caused 688,562 (635,323–739,571) deaths in females and 12,098 (10,693–13,322) deaths in males, globally. The all‐age number of deaths and disability‐adjusted life years attributed to BC risk factors in females had an increasing pattern, with a more prominent pattern in metabolic risks. The global estimated age‐standardized QCI for BC in females in 2019 was 78.7. The estimated QCI was highest in high SDI regions (95.7). The top countries with the highest calculated QCI in 2019 were Iceland (100), Japan (99.8), and Finland (98.8), and the bottom countries were Mozambique (16.0), Somalia (8.2), and Central African Republic (5.3). The global estimated age‐standardized rQCI for females was 82.2 in 2019. CONCLUSION: In spite of the partially restrained burden of BC in recent years, the attributable burden to risk factors has increased remarkably. Countries with higher SDI provided better care regarding both the condition and its responsible risk factors.
format Text
author Azadnajafabad, Sina
Saeedi Moghaddam, Sahar
Keykhaei, Mohammad
Shobeiri, Parnian
Rezaei, Negar
Ghasemi, Erfan
Mohammadi, Esmaeil
Ahmadi, Naser
Ghamari, Azin
Shahin, Sarvenaz
Rezaei, Nazila
Aghili, Mahdi
Kaviani, Ahmad
Larijani, Bagher
Farzadfar, Farshad
author_facet Azadnajafabad, Sina
Saeedi Moghaddam, Sahar
Keykhaei, Mohammad
Shobeiri, Parnian
Rezaei, Negar
Ghasemi, Erfan
Mohammadi, Esmaeil
Ahmadi, Naser
Ghamari, Azin
Shahin, Sarvenaz
Rezaei, Nazila
Aghili, Mahdi
Kaviani, Ahmad
Larijani, Bagher
Farzadfar, Farshad
author_sort Azadnajafabad, Sina
title Expansion of the quality of care index on breast cancer and its risk factors using the global burden of disease study 2019
title_short Expansion of the quality of care index on breast cancer and its risk factors using the global burden of disease study 2019
title_full Expansion of the quality of care index on breast cancer and its risk factors using the global burden of disease study 2019
title_fullStr Expansion of the quality of care index on breast cancer and its risk factors using the global burden of disease study 2019
title_full_unstemmed Expansion of the quality of care index on breast cancer and its risk factors using the global burden of disease study 2019
title_sort expansion of the quality of care index on breast cancer and its risk factors using the global burden of disease study 2019
publisher John Wiley and Sons Inc.
publishDate 2022
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883412/
http://www.ncbi.nlm.nih.gov/pubmed/35770711
https://doi.org/10.1002/cam4.4951
genre Iceland
genre_facet Iceland
op_source Cancer Med
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883412/
http://www.ncbi.nlm.nih.gov/pubmed/35770711
http://dx.doi.org/10.1002/cam4.4951
op_rights © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
op_rightsnorm CC-BY
op_doi https://doi.org/10.1002/cam4.4951
container_title Cancer Medicine
container_volume 12
container_issue 2
container_start_page 1729
op_container_end_page 1743
_version_ 1766042363130544128